We’re the droplet microfluidic technology company for single-cell analysis. We work small so you can think big. #SphereBio
Cambridge, UK
Joined December 2010
- Tweets2.2K
- Following1.2K
- Followers1.6K
- Likes263
Sphere Bio Ltd retweeted
Today @SphereFluidics announced the establishment of a direct sales channel in North America and several key global commercial leadership changes to address global demand for the Cyto-Mine® Chroma platform.
More here: rb.gy/edi4yh
Sphere Bio Ltd retweeted
Guide: The benefits and advances in cell line development.
View the Guide
cygdq04.na1.hubspotlinks.com…
Sponsored by @SphereFluidics and @SartoriusGlobal
#CellLineDevelopment
Sphere Bio Ltd retweeted
.@SphereFluidics today announced the appointment of Ed Rayner to its Board of Directors as a Non-Executive Director.
Ed’s appointment will strengthen the Company’s strategic vision as it progresses ambitious plans for future growth and commercial success: rb.gy/x59rv2
Sphere Bio Ltd retweeted
So proud of the unstoppable @antonia_molloy talking about her PhD research @AstonUniversity funded by @CDTLifETIME and partnered with @SphereFluidics @MicrobioSoc #microsoc24 On droplet fluidics for antibiotic susceptibility testing 👏 🤩 🥂
Sphere Bio Ltd retweeted
Read our latest blog by @antonia_molloy from @AstonUniversity about her placement at @SphereFluidics earlier this year.
Read the full blog post here: lifetime-cdt.org/2023/10/12/…
Sphere Bio Ltd retweeted
.@SphereFluidics today announced that FairJourney Biologics has adopted the Cyto-Mine® platform as part of the launch for its latest cell line development services, to streamline and accelerate customer workflows.
Read more here: rb.gy/k0m0k
Sphere Bio Ltd retweeted
A robust cell line development process is pivotal for the large-scale production of #biopharmaceuticals. In this article, we speak with Richard Hammond about the key technology driving quality and efficiency in cell line development.
@SphereFluidics
... selectscience.net/editorial-…
Sphere Bio Ltd retweeted
.@SphereFluidics today announced updates to its Cyto-Mine® platform, including 21CFR Part 11 & a full IQ/OQ package, to provide a cGMP-compliant solution to enhance cell line characterization & selection within drug manufacture workflows: rb.gy/5yqga
Sphere Bio Ltd retweeted
Great coverage from @businessweekly on @SphereFluidics's new branding, which was launched to reflect its customer-centric approach following a period of significant growth.
ow.ly/11wt50OSGE4
Sphere Bio Ltd retweeted
.@SphereFluidics announced @biosyntia has adopted the Pico-Mine® platform within its workflows to harness Pico-Mine's ultra-high-throughput, picodroplet-based #screening capabilities, to advance bio-based production of nutritional ingredients.
More here: rb.gy/r4m3v
Sphere Bio Ltd retweeted
Sphere Fluidics' platform chosen by Biosyntia for screening capabilities manufacturingchemist.com/new…
Sphere Bio Ltd retweeted
Loved hosting lunch at the Microfluidics Consortium last week. Great to bring together thought leaders from @MIT, @CepheidNews, @SphereFluidics, @QIAGEN, @LLNL_SciTech, @broadinstitute, @kytopen, @ipggmicrofluid, @flowcircuits, and beyond! Thanks @PeterHewkin #microfluidics
Sphere Bio Ltd retweeted
Fantastic to see five companies from the @Cambridge_Uni on @Siftedeu's list of 15 university spin-outs to watch in Europe. bit.ly/3NgD5PR
@biomodalhq @colorifix @nyobolt @SphereFluidics @polyaivoice
Sphere Bio Ltd retweeted
Pop by @SphereFluidics at #325 to learn more about how the Company’s novel microfluidic tools are streamlining the journey of discovery in labs.
Fantastic to see the Company’s new branding, launched at the conference!
Learn more: spherefluidics.com/sphere-fl… #SLASEUROPE2023
Sphere Bio Ltd retweeted
.@SphereFluidics today introduced new branding to align with its ambitious global commercial growth strategy, better reflect the Company’s customer-centric approach and showcase its pioneering single cell analysis #technology: rb.gy/8wf44
Sphere Bio Ltd retweeted
Cambridge life science company @SphereFluidics is part of a consortium awarded €3.4m for a new cancer research programme. 3DSecret is a four-year research project funded through the @EUeic’s Pathfinder Open 2022, established under Horizon Europe. bit.ly/41XDRG9 @INLnano
Sphere Bio Ltd retweeted
#3DSecret kicked off in the last week of February in Braga - Portugal, under the coordination of @INLnano with @SphereFluidics, @uvigo, @FBK_research, 2CA-Braga, and @tecnalia.
+ Read the full update: lnkd.in/dhG5tvD7
#inl #inlnano #EICPathfinder #EUeic @EUeic
Sphere Bio Ltd retweeted
EVENT: The #EISingleCell23 Symposium is supported by @biouea and @Co_Biologists.
With thanks to our sponsors: @biotechne, @Cellenion, @iotasciences, @JumpcodeG, @PacBio, @ParseBio, @SphereFluidics and @vizgen_inc.
⏰ Submit your abstract by 28 Feb!
➡ okt.to/vEKsYA
ALT Supporter and sponsor logos of the Norwich Single Cell Symposium: University of East Anglia, the Company of Biologists, Bio-Techne, Cellenion, IotaSciences, Jumpcode Genomics, PacBio, Parse Biosciences, Sphere Fluidics and Vizgen. Register via link in text.
Sphere Bio Ltd retweeted
We have a PhD project available at @UofGlasgow - High-throughput electrical characterization of living cells in droplets.
This project will be supervised by Dr Julien Reboud & @SphereFluidics
More info: lifetime-cdt.org/project-pag…
Application deadline: 31 Jan 2023
#FindAPhD
Sphere Bio Ltd retweeted
PhD available at @UofGlasgow working on: High-throughput electrical characterization of living cells in droplets with Dr Julien Reboud & @SphereFluidics
Deadline: 31 Jan
Apply here: lifetime-cdt.org/apply/
ALT Sphere Fluidics